Zyactinase stimulates the probiotic gut microflora whilst inhibiting pathogenic microflora

International Journal of Probiotics and Prebiotics

Volumn 3, Issue 4, 2008, Pages 231-238

  Weir, Iona E ^a   Peng, Robert ^b   Bian, Michael L ^b   Matharu, Kawal ^a   Shu, Quan ^b  

^a Vital Foods Processors Ltd   (New Zealand)

^b THE NEW ZEALAND INSTITUTE FOR PLANT AND FOOD RESEARCH LIMITED   (New Zealand)

Author keywords

Constipation; Kiwifruit; Prebiotic; Zyactinase

Indexed keywords

FRUCTOSE OLIGOSACCHARIDE; HERBACEOUS AGENT; ISOMALT; MAGNESIUM STEARATE; PECTIN; PHLOE; PROBIOTIC AGENT; PROTEASOME; SILICON DIOXIDE; UNCLASSIFIED DRUG; ZYACTINASE;

ARTICLE; BACTERIAL GROWTH; BACTERIUM CULTURE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG EFFICACY; DRUG ISOLATION; DRUG RESEARCH; ESCHERICHIA COLI; GROWTH INHIBITION; HEATING; INTESTINE FLORA; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS PLANTARUM; LACTOBACILLUS REUTERI; LISTERIA MONOCYTOGENES; NONHUMAN; PEDIOCOCCUS ACIDILACTICI; SALMONELLA TYPHIMURIUM; STAPHYLOCOCCUS AUREUS;

EID: 60749102939     PISSN: 15551431     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Bekkali, N. L. H., Bongers,M. E.G., Van den Berg, M.M., Liem, O. and Benninga, M. A. (2007) The role of a probiotics mixture in the treatment of childhood constipation: a pilot study. Nutrition Journal 6, 17.
2. Brown, A. C., Shovic, A., Ibrahim, S., Holck, P. and Huang, A. (2005) A non-dairy probiotic's (POI) influence on changing the gastrointestinal tract's microflora environment. Alternative Therapy Health Medicine 11, 58-64.
3. Brown, A. C. and Valiere, A. (2004) Probiotics and Medical Nutrition Therapy Nutrition and Clinical Care. 7, 56-68.
4. Cleusix, V., Lacroix, C., Vollenweider, S., Duboux, M. and Le Blay, G. (2007) Inhibitory activity spectrum of reuterin produced by Lactobacillus reuteri against intestinal bacteria. BMC Microbiology 7, 101.
5. Code, K. (2006) Use of isomalt (mixture of 1,6 gps and 1,1 gpm) as a prebiotic for the production of a medicament used for the treatment of intestinal diseases, among other things IN PATENT, U. S. (Ed.) 20060147500.
6. Drakes, M., Blanchard, T. and Czinn, S. (2004) Bacterial Probiotic Modulation of Dendritic Cells. Infection and Immunity 72, 3299-3309.
7. Ghosh, S., Van Heel, D. and Playford, R. J. (2004) Probiotics in inflammatory bowel disease: is it all gut flora modulation? Gut 53, 620-622.
8. Gill, H. S., Shu, Q., Lin, H., Rutherford, K. J. and Cross, M. C. (2002) Protection against translocating Salmonella typhimurium infection in mice by feeding the immuno-enhancing probiotic Lactobacillus rhamnosus strain HN001. Medical Microbial Immunology 190, 97-104.
9. Hart, A. L., Lammers, K., Brigidi, P., Vitali, B., Rizzello, F., Gionchetti, P., Campieri, M., Kamm, M. A., Knight, S. C. and Stagg, A. J. (2004) Modulation of human dendritic cell phenotype and function by probiotic bacteria. Gut 53, 1602-1609.
10. Holdeman, L.V. and Moore, W.E. (1972) Roll-tube techniques for anaerobic bacteria. American Journal of Clinical Nutrition 25, 1314-1317.
11. Mohamadzadeh, M., Olson, S., Kalina, W.V., Ruthel, G., Demmin, G. L., Warfield, K. L., Bavari, S. and Klaenhammer T. R. (2005) Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization. Proceedings of the National Academy of Science 102, 2880-2885.
12. Molis, C., Flourie, B., Ouarne, F., Gailing, M. F., Lartigue, S., Guibert, A., Bornet, F. and Galmiche, J. P. (1996) Digestion, excretion, and energy value of fructooligosaccharides in healthy humans. American Journal of Clinical Nutrition 64, 324-328.
13. Peña, J. A., Rogers, A. B., Ge, Z., Ng, V., Li, S. Y., Fox, J. G. and Versalovic, J. (2005) Probiotic Lactobacillus spp. Diminish Helicobacter hepaticus-Induced Inflammatory Bowel Disease in Interleukin-10-Deficient Mice. Infection and Immunity 73, 912-920.
14. Shoaf, K., Mulvey, G. L., Armstrong, G. D. and Hutkins, R. W. (2006) Prebiotic Galactooligosaccharides Reduce Adherence of Enteropathogenic Escherichia coli to Tissue Culture Cells. Infection and Immunity 74, 6920-6928.
15. Shu, Q. and Gill, H. S. (2002) Immune protection mediated by the probiotic Lactobacillus rhamnosus HN001 (DR20) against Escherichia coli O157:H7 infection in mice. FEMS Immunology and Medical Microbiology 6, 59-64.
16. Talarico, T. L., Casas, I. A., Chung, T. C. and Dobrogosz, W. J. (1988) Production and isolation of reuterin, a growth inhibitor produced by Lactobacillus reuteri. Antimicrobial Agents and Chemotherapy 32, 1854-1858.
17. Ten Bruggencate, S. J. M., Bovee-Oudenhoven, I. M. J., Lettink Wissink, M. L. G., Katan, M. B. and Vander Meer, R. (2004) Dietary fructo-oligosaccharides and inulin decrease resistance of rats to salmonella: protective role of calcium. Gut 53, 530-535.